Drug maker Krka sees group net profit rise 26% in Q3
Novo Mesto, 17 November - Pharma company Krka posted a record net profit of just under EUR 302 million for January-September, an increase of 26% over the year before, as revenue rose by 6% to EUR 1.24 billion, also a new record, according to the interim report released on Thursday.
The rest of this news item is available to subscribers.
The news item consists of 736 characters (without spaces) or 146 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.